Medicine
Kerendia 20 mg tablet
Kerendia 20 mg tablet is a prescription medicine containing Finerenone for oral use, marketed by Bayer HealthCare Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions are permitted from 15°C to…
Key facts
- Active ingredient (INN)
- Finerenone
- Brand
- Kerendia
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets, 10 tablets and 1 more
- Marketing authorisation holder
- Bayer HealthCare Pharmaceuticals
- Manufacturer
- Bayer HealthCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions are permitted from 15°C to 30°C (59°F to 86°F ).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09 ACE inhibitors, sartans and other renin-angiotensin medicines
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 July 2021
- Identifiers
- RxCUI 2562816, 2562822, 2562824 +3DailyMed set ID fc726765-5d5a-4d6e-b037-b847bda9fb7cNDC 50419-541Application NDA215341
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle, plastic | 50419-541-01 | Bayer HealthCare Pharmaceuticals | 9 July 2021 |
| 90 tablet, film coated in 1 bottle, plastic | 50419-541-02 | Bayer HealthCare Pharmaceuticals | 9 July 2021 |
| 10 tablet, film coated in 1 blister pack | 50419-541-06 | Bayer HealthCare Pharmaceuticals | 23 August 2025 |
| 7 tablet, film coated in 1 bottle, plastic | 50419-541-70 | Bayer HealthCare Pharmaceuticals | 9 July 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Finerenone
Clinical summary
Finerenone is a nonsteroidal mineralocorticoid-receptor antagonist indicated to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Finerenone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FinerenoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Kerendia prescribing information (Bayer HealthCare Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Kerendia: European public assessment report (EPAR) · European Medicines Agency
Need Kerendia 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.